Trial
NCT03333551
Cardiac Uptake of 18F Florbetapir in Patients Undergoing Chemotherapy
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Medical College of Wisconsin
Collaborators
—
Condition
Cardiac Amyloidosis
Intervention
F18 Florbetapir (amyvid) cardiac PET/CT imaging
Why stopped
slow recruitment.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-05-09